Dr. Durand completed training in clinical and basic science. He completed his residency in internal medicine, at Loyola University School of Medicine in Chicago. His training continued at Baylor College of Medicine as an American Heart Association/Bugher Foundation Fellowship in Molecular Biology investigating Hypertrophic Cardiomyopathy, Sudden Cardiac Death and Dilated Cardiomyopathy. He was awarded a Robert Woods Johnson Fellowship at Baylor College of Medicine in Molecular Genetics. This body of work lead to Localization of a gene to Chromosome 1q32 and Identification of the gene as Troponin, one of the first genes for Familial dilated Cardiomyopathy.

After Completion of his clinical fellowship at Baylor College of Medicine, He also completed clinical fellowship in Immunology/Advanced Heart Failure/ Circulatory Support and Cardiac Transplantation. He served as Assistant Medical Director of the Heart Transplant Service at Baylor College of Medicine and Houston Methodist Hospital. 

He was recruited to MD Anderson Cancer Center to establish a cardiomyopathy program and a fully integrated interventional cardiology program. He was the first in the world to establish a cardiomyopathy service within a cancer hospital and was able to establish standards for cardioprotection prior to Anthracycline based therapies and investigate novel mechanisms which lead to recovery of cardiac function in chemotherapy induced cardiomyopathy from Anthracyclines, Tyrosine Kinase Inhibitors and radiation induced cardiomyopathy.

Dr Durand developed the largest DNA/Tissue bank of Chemotherapy induced Cardiomyopathy to detect polymorphisms to predict risk of development of heart failure. He has developed the first cardiac device clinic at MD Anderson utilizing mobile device monitoring of patients with arrhythmias’ and heart failure. While at MD Anderson Cancer Center he was responsible for developing a multidisciplinary program for diagnosis, management and novel approaches to perform cardiac biopsies and novel treatment regimens for cardiac tumors. His active research includes understanding technologies to predict and recover heart function. He is the Co-Principal investigator for several clinical trials in using stem cell therapy to treat chemotherapy related heart injury. He has over 100 publications in peer reviewed journals.

He serves as an IRB Co-chair and is a national and international speaker for cardioncology, he was recently appointed to the American Heart Association New Cardioncology Council and serves as Co-PI on several clinical trials for Stem Cell Therapy for Anthracycline- induced Cardiomyopathy.

Dr. Durand has maintained a network of mentoring Science and Technology through several forums. He is a consultant for Baylor College of Medicine, SMART program to mentor young underrepresented minorities in healthcare such as medicine, science and pharmacy a role he has maintained for 25 years. He also is a mentor in a local organization, Suits for Sons and mentors college students for professional careers. \

He served as Director of Cardiovascular Fellowship program at MD Anderson Cancer Center for 10 years. He developed a Financial Bootcamp for Cardiovascular Fellows in 2004 that is now serving the Texas medical center Fellows programs and has taught over 1000 fellows regarding financial literacy. He has completed executive training with Harvard, Kellogg, Wharton and has certification from MIT Sloan School of Business with a specialty in Marketing and Finance. He is a member of the American Association of Individual Investors, Financial Therapy Association and Han (Houston Angel Network)He serves as a consultant to the Texas Medical Center Biotech Center (TMCX) He has invested in Real Estate, Biotech start- ups, IPOs, and Start Up companies.

He is completing his certification as Life/Career Coach at Rice University- CoachRice program. 

His areas of expertise are retirement investing, college planning for kids, Wealth management and “tricks of the Trade of strategic investment planning.

LinkedIn